Literature DB >> 1351032

Genetics of neurofibromatosis 1 in Japan: mutation rate and paternal age effect.

T Takano1, T Kawashima, Y Yamanouchi, K Kitayama, T Baba, K Ueno, H Hamaguchi.   

Abstract

We have performed formal genetic studies on 26 patients (14 males, 12 females) with neurofibromatosis 1 (von Recklinghausen's disease, NF1) in Japan. Family studies of 74 members of 18 kindreds revealed that 50% of the cases were caused by a new mutation; the mutation rate was assumed to be 7.3-10.5 x 10(-5). A tendency of paternal age effect, which was not accounted for by the maternal age effect, was observed, but live-birth order had no significant effect. Genetic linkage of neurofibromatosis 1 to the NF1 gene or the genetic marker in the pericentric region of chromosome 17 was established in 3 informative families.

Entities:  

Mesh:

Year:  1992        PMID: 1351032     DOI: 10.1007/bf00220540

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  On the mutation rate of neurofibromatosis.

Authors:  A S Sergeyev
Journal:  Humangenetik       Date:  1975-06-19

2.  BclI RFLP at the NF1 gene locus.

Authors:  K Kitayama; T Arinami; H Hagamuchi
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

3.  A probable sex difference in some mutation rates.

Authors:  F Vogel
Journal:  Am J Hum Genet       Date:  1977-05       Impact factor: 11.025

4.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

5.  Genetic analysis of NF1: identification of close flanking markers on chromosome 17.

Authors:  P R Fain; D F Barker; D E Goldgar; E Wright; K Nguyen; J Carey; J Johnson; J Kivlin; H Willard; C Mathew
Journal:  Genomics       Date:  1987-12       Impact factor: 5.736

6.  Neurofibromatosis: no chromosomal defect by prophase banding technique.

Authors:  Y S Kao; C S Kao-Shan; T Knutsen; J Whang-Peng; J J Mulvihill
Journal:  Cancer Genet Cytogenet       Date:  1984-11

7.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

8.  Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17.

Authors:  D Barker; E Wright; K Nguyen; L Cannon; P Fain; D Goldgar; D T Bishop; J Carey; B Baty; J Kivlin
Journal:  Science       Date:  1987-05-29       Impact factor: 47.728

9.  The pathophysiology of neurofibromatosis: IX. Paternal age as a factor in the origin of new mutations.

Authors:  V M Riccardi; C E Dobson; R Chakraborty; C Bontke
Journal:  Am J Med Genet       Date:  1984-05

Review 10.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

Authors:  D Botstein; R L White; M Skolnick; R W Davis
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

View more
  8 in total

1.  Parental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry Initiative.

Authors:  Qian Liu; Nancy Zoellner; David H Gutmann; Kimberly J Johnson
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

Review 2.  MAPK pathway activation in pilocytic astrocytoma.

Authors:  David T W Jones; Jan Gronych; Peter Lichter; Olaf Witt; Stefan M Pfister
Journal:  Cell Mol Life Sci       Date:  2011-12-13       Impact factor: 9.261

3.  Novel phenotypes of NF1 patients from unrelated Chinese families with tibial pseudarthrosis and anemia.

Authors:  Santasree Banerjee; Dongzhu Lei; Shengran Liang; Li Yang; Saijun Liu; Zhu Wei; Jian Ping Tang
Journal:  Oncotarget       Date:  2017-06-13

4.  Metachronous bilateral triple-negative breast cancer associated with neurofibromatosis type 1: A case report.

Authors:  Yoji Yamagishi; Takahiro Einama; Tamio Yamasaki; Tomomi Koiwai; Miyuki Hiratsuka; Makiko Fukumura; Takako Kono; Hideki Ueno; Junji Yamamoto; Hitoshi Tsuda
Journal:  Oncol Lett       Date:  2019-01-14       Impact factor: 2.967

5.  Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.

Authors:  Harleen Chohan; Mitra Esfandiarei; Darian Arman; Catherine D Van Raamsdonk; Cornelis van Breemen; Jan M Friedman; Kimberly A Jett
Journal:  PLoS One       Date:  2018-12-20       Impact factor: 3.240

6.  Neurofibromin expression by normal salivary glands.

Authors:  Eloá Borges Luna; Pâmella Pinho Montovani; Rafaela Elvira Rozza-de-Menezes; Karin Soares Cunha
Journal:  Head Face Med       Date:  2021-02-18       Impact factor: 2.151

7.  The effect of parental age on the presence of de novo mutations - Lessons from neurofibromatosis type I.

Authors:  Tom Dubov; Hagit Toledano-Alhadef; Felix Bokstein; Shlomi Constantini; Shay Ben-Shachar
Journal:  Mol Genet Genomic Med       Date:  2016-06-16       Impact factor: 2.183

8.  Parental age and risk of genetic syndromes predisposing to nervous system tumors: nested case-control study.

Authors:  Maral Adel Fahmideh; Giorgio Tettamanti; Catharina Lavebratt; Mats Talbäck; Tiit Mathiesen; Birgitta Lannering; Kimberly J Johnson; Maria Feychting
Journal:  Clin Epidemiol       Date:  2018-06-20       Impact factor: 4.790

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.